A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women.
Shadab A RahmanMargo D NathanAleta WileySybil CrawfordAviva Y CohnJessica A HarderLeilah K GrantAthena EricksonAkanksha SrivastavaKathleen McCormickSuzanne M BertischJohn W WinkelmanHadine JoffePublished in: Sleep (2022)
Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia, https://clinicaltrials.gov/ct2/show/NCT03034018, ClinicalTrials.gov Identifier: NCT03034018.